Review



human hcc hepg2 cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC human hcc hepg2 cells
    Evaluation of cytotoxicity profiles of SRHC nanoparticles. The dose-response curve illustrates the relationship between the cytotoxicity percentage of SRHC (blue) and conjugated NPs (Polymer-SRHC) (red) on <t>HepG2</t> cells and the concentration in nmol. The IC 50 values of SRHC and conjugated NPs (Polymer-SRHC) were determined from the curve to be 98.8 nmol and 95.24, respectively.
    Human Hcc Hepg2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 29293 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+cells/pmc13157485-70-0-4?v=ATCC
    Average 99 stars, based on 29293 article reviews
    human hcc hepg2 cells - by Bioz Stars, 2026-06
    99/100 stars

    Images

    1) Product Images from "Development of an innovative nanopolymer-lncRNA-SRHC complex as therapeutic modalities for targeted hepatocellular carcinoma therapy"

    Article Title: Development of an innovative nanopolymer-lncRNA-SRHC complex as therapeutic modalities for targeted hepatocellular carcinoma therapy

    Journal: Scientific Reports

    doi: 10.1038/s41598-026-51340-1

    Evaluation of cytotoxicity profiles of SRHC nanoparticles. The dose-response curve illustrates the relationship between the cytotoxicity percentage of SRHC (blue) and conjugated NPs (Polymer-SRHC) (red) on HepG2 cells and the concentration in nmol. The IC 50 values of SRHC and conjugated NPs (Polymer-SRHC) were determined from the curve to be 98.8 nmol and 95.24, respectively.
    Figure Legend Snippet: Evaluation of cytotoxicity profiles of SRHC nanoparticles. The dose-response curve illustrates the relationship between the cytotoxicity percentage of SRHC (blue) and conjugated NPs (Polymer-SRHC) (red) on HepG2 cells and the concentration in nmol. The IC 50 values of SRHC and conjugated NPs (Polymer-SRHC) were determined from the curve to be 98.8 nmol and 95.24, respectively.

    Techniques Used: Polymer, Concentration Assay



    Similar Products

    99
    ATCC human hcc hepg2 cells
    Evaluation of cytotoxicity profiles of SRHC nanoparticles. The dose-response curve illustrates the relationship between the cytotoxicity percentage of SRHC (blue) and conjugated NPs (Polymer-SRHC) (red) on <t>HepG2</t> cells and the concentration in nmol. The IC 50 values of SRHC and conjugated NPs (Polymer-SRHC) were determined from the curve to be 98.8 nmol and 95.24, respectively.
    Human Hcc Hepg2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+cells/pmc13157485-70-0-4?v=ATCC
    Average 99 stars, based on 1 article reviews
    human hcc hepg2 cells - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    86
    Procell Inc human hcc cell lines
    Identification and multi-level validation of TPI1 as a pivotal prognostic driver. (A) Lollipop chart showing the selection frequency of feature genes across 101 machine learning models, identifying TPI1 as a high-frequency core gene. (B) Univariate Cox regression analysis of candidate genes; TPI1 exhibited the most substantial Hazard Ratio (HR), characterizing it as a preeminent risk factor. (C) Expression profiling of TPI1 across malignant versus paracancerous tissues within the TCGA-LIHC discovery cohort (upper) and GSE14520 validation cohort (lower). (D) Kaplan-Meier overall survival curves comparing patients with high and low TPI1 expression in the TCGA-LIHC (top) and GSE14520 (bottom) cohorts. (E) Relative mRNA expression levels of TPI1 in the immortalized human hepatocyte line (MIHA) and <t>HCC</t> cell <t>lines</t> <t>(Huh7,</t> SMMC-7721) determined by RT-qPCR. (F) Representative Western blot images (left) and densitometric quantification (right) of TPI1 protein levels in MIHA, Huh7, and SMMC-7721 cells. GAPDH served as the internal loading control. Data are expressed as mean ± SD. ** P < 0.01, *** P < 0.001.
    Human Hcc Cell Lines, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+cells/pmc13199849-113-1-18?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    human hcc cell lines - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Servicebio Inc hcc cell lines
    Identification and multi-level validation of TPI1 as a pivotal prognostic driver. (A) Lollipop chart showing the selection frequency of feature genes across 101 machine learning models, identifying TPI1 as a high-frequency core gene. (B) Univariate Cox regression analysis of candidate genes; TPI1 exhibited the most substantial Hazard Ratio (HR), characterizing it as a preeminent risk factor. (C) Expression profiling of TPI1 across malignant versus paracancerous tissues within the TCGA-LIHC discovery cohort (upper) and GSE14520 validation cohort (lower). (D) Kaplan-Meier overall survival curves comparing patients with high and low TPI1 expression in the TCGA-LIHC (top) and GSE14520 (bottom) cohorts. (E) Relative mRNA expression levels of TPI1 in the immortalized human hepatocyte line (MIHA) and <t>HCC</t> cell <t>lines</t> <t>(Huh7,</t> SMMC-7721) determined by RT-qPCR. (F) Representative Western blot images (left) and densitometric quantification (right) of TPI1 protein levels in MIHA, Huh7, and SMMC-7721 cells. GAPDH served as the internal loading control. Data are expressed as mean ± SD. ** P < 0.01, *** P < 0.001.
    Hcc Cell Lines, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+cells/pm42281194-27-0-13?v=Servicebio+Inc
    Average 86 stars, based on 1 article reviews
    hcc cell lines - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc mahlavu human hcc cell line
    Identification and multi-level validation of TPI1 as a pivotal prognostic driver. (A) Lollipop chart showing the selection frequency of feature genes across 101 machine learning models, identifying TPI1 as a high-frequency core gene. (B) Univariate Cox regression analysis of candidate genes; TPI1 exhibited the most substantial Hazard Ratio (HR), characterizing it as a preeminent risk factor. (C) Expression profiling of TPI1 across malignant versus paracancerous tissues within the TCGA-LIHC discovery cohort (upper) and GSE14520 validation cohort (lower). (D) Kaplan-Meier overall survival curves comparing patients with high and low TPI1 expression in the TCGA-LIHC (top) and GSE14520 (bottom) cohorts. (E) Relative mRNA expression levels of TPI1 in the immortalized human hepatocyte line (MIHA) and <t>HCC</t> cell <t>lines</t> <t>(Huh7,</t> SMMC-7721) determined by RT-qPCR. (F) Representative Western blot images (left) and densitometric quantification (right) of TPI1 protein levels in MIHA, Huh7, and SMMC-7721 cells. GAPDH served as the internal loading control. Data are expressed as mean ± SD. ** P < 0.01, *** P < 0.001.
    Mahlavu Human Hcc Cell Line, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+cells/pm42265080-90-1-15?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    mahlavu human hcc cell line - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc human hcc cell line hepg2
    Identification and multi-level validation of TPI1 as a pivotal prognostic driver. (A) Lollipop chart showing the selection frequency of feature genes across 101 machine learning models, identifying TPI1 as a high-frequency core gene. (B) Univariate Cox regression analysis of candidate genes; TPI1 exhibited the most substantial Hazard Ratio (HR), characterizing it as a preeminent risk factor. (C) Expression profiling of TPI1 across malignant versus paracancerous tissues within the TCGA-LIHC discovery cohort (upper) and GSE14520 validation cohort (lower). (D) Kaplan-Meier overall survival curves comparing patients with high and low TPI1 expression in the TCGA-LIHC (top) and GSE14520 (bottom) cohorts. (E) Relative mRNA expression levels of TPI1 in the immortalized human hepatocyte line (MIHA) and <t>HCC</t> cell <t>lines</t> <t>(Huh7,</t> SMMC-7721) determined by RT-qPCR. (F) Representative Western blot images (left) and densitometric quantification (right) of TPI1 protein levels in MIHA, Huh7, and SMMC-7721 cells. GAPDH served as the internal loading control. Data are expressed as mean ± SD. ** P < 0.01, *** P < 0.001.
    Human Hcc Cell Line Hepg2, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+cells/pmc13197829-63-1-7?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    human hcc cell line hepg2 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc 120 hcc cell lines
    Identification and multi-level validation of TPI1 as a pivotal prognostic driver. (A) Lollipop chart showing the selection frequency of feature genes across 101 machine learning models, identifying TPI1 as a high-frequency core gene. (B) Univariate Cox regression analysis of candidate genes; TPI1 exhibited the most substantial Hazard Ratio (HR), characterizing it as a preeminent risk factor. (C) Expression profiling of TPI1 across malignant versus paracancerous tissues within the TCGA-LIHC discovery cohort (upper) and GSE14520 validation cohort (lower). (D) Kaplan-Meier overall survival curves comparing patients with high and low TPI1 expression in the TCGA-LIHC (top) and GSE14520 (bottom) cohorts. (E) Relative mRNA expression levels of TPI1 in the immortalized human hepatocyte line (MIHA) and <t>HCC</t> cell <t>lines</t> <t>(Huh7,</t> SMMC-7721) determined by RT-qPCR. (F) Representative Western blot images (left) and densitometric quantification (right) of TPI1 protein levels in MIHA, Huh7, and SMMC-7721 cells. GAPDH served as the internal loading control. Data are expressed as mean ± SD. ** P < 0.01, *** P < 0.001.
    120 Hcc Cell Lines, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+cells/pm42152082-315-0-12?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    120 hcc cell lines - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Jackson Laboratory hcc cells
    Identification and multi-level validation of TPI1 as a pivotal prognostic driver. (A) Lollipop chart showing the selection frequency of feature genes across 101 machine learning models, identifying TPI1 as a high-frequency core gene. (B) Univariate Cox regression analysis of candidate genes; TPI1 exhibited the most substantial Hazard Ratio (HR), characterizing it as a preeminent risk factor. (C) Expression profiling of TPI1 across malignant versus paracancerous tissues within the TCGA-LIHC discovery cohort (upper) and GSE14520 validation cohort (lower). (D) Kaplan-Meier overall survival curves comparing patients with high and low TPI1 expression in the TCGA-LIHC (top) and GSE14520 (bottom) cohorts. (E) Relative mRNA expression levels of TPI1 in the immortalized human hepatocyte line (MIHA) and <t>HCC</t> cell <t>lines</t> <t>(Huh7,</t> SMMC-7721) determined by RT-qPCR. (F) Representative Western blot images (left) and densitometric quantification (right) of TPI1 protein levels in MIHA, Huh7, and SMMC-7721 cells. GAPDH served as the internal loading control. Data are expressed as mean ± SD. ** P < 0.01, *** P < 0.001.
    Hcc Cells, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+cells/bio_rxiv__64898__2026__05__12__724215-65-14-26?v=Jackson+Laboratory
    Average 86 stars, based on 1 article reviews
    hcc cells - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc hcc cells
    SOX2 is highly expressed in hepatocellular carcinoma <t>(HCC)</t> cell lines. (a-c) qRT-PCR and Western blot analysis of SOX2 mRNA and protein expression levels in normal <t>liver</t> <t>epithelial</t> (THLE2) and HCC <t>(Huh7)</t> cell lines. (d-f) qRT-PCR and Western blot validation of transfection efficiency in Huh7 cells transfected with shRNA targeting SOX2 (shSOX2) or SOX2 overexpression plasmids. n = 6; ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, qRT-PCR: Quantitative reverse transcription polymerase chain reaction. mRNA: messenger RNA; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; sh-NC: shRNA-negative control; Oe-NC: overexpression plasmid negative control.
    Hcc Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+cells/pmc13255168-39-8-15?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    hcc cells - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc hepg2 human hcc cell line
    SOX2 is highly expressed in hepatocellular carcinoma <t>(HCC)</t> cell lines. (a-c) qRT-PCR and Western blot analysis of SOX2 mRNA and protein expression levels in normal <t>liver</t> <t>epithelial</t> (THLE2) and HCC <t>(Huh7)</t> cell lines. (d-f) qRT-PCR and Western blot validation of transfection efficiency in Huh7 cells transfected with shRNA targeting SOX2 (shSOX2) or SOX2 overexpression plasmids. n = 6; ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, qRT-PCR: Quantitative reverse transcription polymerase chain reaction. mRNA: messenger RNA; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; sh-NC: shRNA-negative control; Oe-NC: overexpression plasmid negative control.
    Hepg2 Human Hcc Cell Line, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+cells/pm42108395-49-8-16?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    hepg2 human hcc cell line - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    Image Search Results


    Evaluation of cytotoxicity profiles of SRHC nanoparticles. The dose-response curve illustrates the relationship between the cytotoxicity percentage of SRHC (blue) and conjugated NPs (Polymer-SRHC) (red) on HepG2 cells and the concentration in nmol. The IC 50 values of SRHC and conjugated NPs (Polymer-SRHC) were determined from the curve to be 98.8 nmol and 95.24, respectively.

    Journal: Scientific Reports

    Article Title: Development of an innovative nanopolymer-lncRNA-SRHC complex as therapeutic modalities for targeted hepatocellular carcinoma therapy

    doi: 10.1038/s41598-026-51340-1

    Figure Lengend Snippet: Evaluation of cytotoxicity profiles of SRHC nanoparticles. The dose-response curve illustrates the relationship between the cytotoxicity percentage of SRHC (blue) and conjugated NPs (Polymer-SRHC) (red) on HepG2 cells and the concentration in nmol. The IC 50 values of SRHC and conjugated NPs (Polymer-SRHC) were determined from the curve to be 98.8 nmol and 95.24, respectively.

    Article Snippet: Human HCC HepG2 cells (ATCC HB-8065) were cultured in 25 cm 2 culture flasks.

    Techniques: Polymer, Concentration Assay

    Identification and multi-level validation of TPI1 as a pivotal prognostic driver. (A) Lollipop chart showing the selection frequency of feature genes across 101 machine learning models, identifying TPI1 as a high-frequency core gene. (B) Univariate Cox regression analysis of candidate genes; TPI1 exhibited the most substantial Hazard Ratio (HR), characterizing it as a preeminent risk factor. (C) Expression profiling of TPI1 across malignant versus paracancerous tissues within the TCGA-LIHC discovery cohort (upper) and GSE14520 validation cohort (lower). (D) Kaplan-Meier overall survival curves comparing patients with high and low TPI1 expression in the TCGA-LIHC (top) and GSE14520 (bottom) cohorts. (E) Relative mRNA expression levels of TPI1 in the immortalized human hepatocyte line (MIHA) and HCC cell lines (Huh7, SMMC-7721) determined by RT-qPCR. (F) Representative Western blot images (left) and densitometric quantification (right) of TPI1 protein levels in MIHA, Huh7, and SMMC-7721 cells. GAPDH served as the internal loading control. Data are expressed as mean ± SD. ** P < 0.01, *** P < 0.001.

    Journal: Translational Oncology

    Article Title: Integrating spatial and single-cell transcriptomics via machine learning to characterize efferocytosis in hepatocellular carcinoma prognosis and immunotherapy

    doi: 10.1016/j.tranon.2026.102801

    Figure Lengend Snippet: Identification and multi-level validation of TPI1 as a pivotal prognostic driver. (A) Lollipop chart showing the selection frequency of feature genes across 101 machine learning models, identifying TPI1 as a high-frequency core gene. (B) Univariate Cox regression analysis of candidate genes; TPI1 exhibited the most substantial Hazard Ratio (HR), characterizing it as a preeminent risk factor. (C) Expression profiling of TPI1 across malignant versus paracancerous tissues within the TCGA-LIHC discovery cohort (upper) and GSE14520 validation cohort (lower). (D) Kaplan-Meier overall survival curves comparing patients with high and low TPI1 expression in the TCGA-LIHC (top) and GSE14520 (bottom) cohorts. (E) Relative mRNA expression levels of TPI1 in the immortalized human hepatocyte line (MIHA) and HCC cell lines (Huh7, SMMC-7721) determined by RT-qPCR. (F) Representative Western blot images (left) and densitometric quantification (right) of TPI1 protein levels in MIHA, Huh7, and SMMC-7721 cells. GAPDH served as the internal loading control. Data are expressed as mean ± SD. ** P < 0.01, *** P < 0.001.

    Article Snippet: The human HCC cell lines (Huh7 and SMMC-7721) and the immortalized human hepatocyte line MIHA were procured from Procell Life Science & Technology Co., Ltd. (Wuhan, China).

    Techniques: Biomarker Discovery, Selection, Expressing, Quantitative RT-PCR, Western Blot, Control

    SOX2 is highly expressed in hepatocellular carcinoma (HCC) cell lines. (a-c) qRT-PCR and Western blot analysis of SOX2 mRNA and protein expression levels in normal liver epithelial (THLE2) and HCC (Huh7) cell lines. (d-f) qRT-PCR and Western blot validation of transfection efficiency in Huh7 cells transfected with shRNA targeting SOX2 (shSOX2) or SOX2 overexpression plasmids. n = 6; ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, qRT-PCR: Quantitative reverse transcription polymerase chain reaction. mRNA: messenger RNA; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; sh-NC: shRNA-negative control; Oe-NC: overexpression plasmid negative control.

    Journal: CytoJournal

    Article Title: SOX2 promotes the progression of hepatocellular carcinoma by targeting FOXJ3 and activating the PI3K/AKT pathway to regulate autophagy and mitophagy

    doi: 10.25259/Cytojournal_164_2025

    Figure Lengend Snippet: SOX2 is highly expressed in hepatocellular carcinoma (HCC) cell lines. (a-c) qRT-PCR and Western blot analysis of SOX2 mRNA and protein expression levels in normal liver epithelial (THLE2) and HCC (Huh7) cell lines. (d-f) qRT-PCR and Western blot validation of transfection efficiency in Huh7 cells transfected with shRNA targeting SOX2 (shSOX2) or SOX2 overexpression plasmids. n = 6; ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, qRT-PCR: Quantitative reverse transcription polymerase chain reaction. mRNA: messenger RNA; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; sh-NC: shRNA-negative control; Oe-NC: overexpression plasmid negative control.

    Article Snippet: Human normal liver epithelial cells (THLE-2, CL-0833) and HCC cells (Huh7, CL-0120) were purchased from Procell (Wuhan, Hubei, China).

    Techniques: Quantitative RT-PCR, Western Blot, Expressing, Biomarker Discovery, Transfection, shRNA, Over Expression, Reverse Transcription, Polymerase Chain Reaction, Negative Control, Plasmid Preparation

    SOX2 promotes the growth of HCC cells. (a and b) EdU staining assessing the effects of SOX2 overexpression or knockdown on Huh7 cell proliferation. (a) Magnification = ×100, Scale bar: 100 μm. (c-f) Transwell assays evaluating the effect of SOX2 on Huh7 cell motility. (c and e) Magnification = ×200, Scale bar: 50 μm. (g and h) Flow cytometry analysis of SOX2 effects on apoptosis in Huh7 cells (PI and Annexin V-FITC stain). n = 6; ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, HCC: Hepatocellular carcinoma. sh-NC: shRNA-negative control; Oe-NC: Overexpression plasmid negative control; ECD-A: Energy Coupled Dye -Area; FITC-A: Fluorescein isothiocyanate -Area.

    Journal: CytoJournal

    Article Title: SOX2 promotes the progression of hepatocellular carcinoma by targeting FOXJ3 and activating the PI3K/AKT pathway to regulate autophagy and mitophagy

    doi: 10.25259/Cytojournal_164_2025

    Figure Lengend Snippet: SOX2 promotes the growth of HCC cells. (a and b) EdU staining assessing the effects of SOX2 overexpression or knockdown on Huh7 cell proliferation. (a) Magnification = ×100, Scale bar: 100 μm. (c-f) Transwell assays evaluating the effect of SOX2 on Huh7 cell motility. (c and e) Magnification = ×200, Scale bar: 50 μm. (g and h) Flow cytometry analysis of SOX2 effects on apoptosis in Huh7 cells (PI and Annexin V-FITC stain). n = 6; ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, HCC: Hepatocellular carcinoma. sh-NC: shRNA-negative control; Oe-NC: Overexpression plasmid negative control; ECD-A: Energy Coupled Dye -Area; FITC-A: Fluorescein isothiocyanate -Area.

    Article Snippet: Human normal liver epithelial cells (THLE-2, CL-0833) and HCC cells (Huh7, CL-0120) were purchased from Procell (Wuhan, Hubei, China).

    Techniques: Staining, Over Expression, Knockdown, Flow Cytometry, shRNA, Negative Control, Plasmid Preparation

    SOX2 induces autophagy and mitophagy in HCC cells. (a-c) Western blot analysis of the effect of SOX2 on the expression levels of autophagy-related proteins LC3II, LC3I, and p62. (d) Transmission electron microscopic observation of autophagosome formation in HCC cells following SOX2 modulation. (e-g) Western blot analysis of the effect of SOX2 on mitophagy-related proteins PINK1, phosphorylated COX4 (p-COX4), and COX4. (h) Immunofluorescence analysis of the colocalization between mitochondria and lysosomes upon SOX2 expression. (i) Relative intensity of overlapping fluorescence signals of mitochondria and lysosomes. (d) and (h) magnification = ×200, Scale bar: 50 μm. n = 6; ✶ P <0.05, ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, HCC: Hepatocellular carcinoma. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; sh-NC: shRNA-negative control; Oe-NC: overexpression plasmid negative control.

    Journal: CytoJournal

    Article Title: SOX2 promotes the progression of hepatocellular carcinoma by targeting FOXJ3 and activating the PI3K/AKT pathway to regulate autophagy and mitophagy

    doi: 10.25259/Cytojournal_164_2025

    Figure Lengend Snippet: SOX2 induces autophagy and mitophagy in HCC cells. (a-c) Western blot analysis of the effect of SOX2 on the expression levels of autophagy-related proteins LC3II, LC3I, and p62. (d) Transmission electron microscopic observation of autophagosome formation in HCC cells following SOX2 modulation. (e-g) Western blot analysis of the effect of SOX2 on mitophagy-related proteins PINK1, phosphorylated COX4 (p-COX4), and COX4. (h) Immunofluorescence analysis of the colocalization between mitochondria and lysosomes upon SOX2 expression. (i) Relative intensity of overlapping fluorescence signals of mitochondria and lysosomes. (d) and (h) magnification = ×200, Scale bar: 50 μm. n = 6; ✶ P <0.05, ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, HCC: Hepatocellular carcinoma. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; sh-NC: shRNA-negative control; Oe-NC: overexpression plasmid negative control.

    Article Snippet: Human normal liver epithelial cells (THLE-2, CL-0833) and HCC cells (Huh7, CL-0120) were purchased from Procell (Wuhan, Hubei, China).

    Techniques: Western Blot, Expressing, Transmission Assay, Immunofluorescence, Fluorescence, shRNA, Negative Control, Over Expression, Plasmid Preparation

    SOX2 regulates the expression of FOXJ3 in HCC. (a-c) qRT-PCR and Western blot analysis of FOXJ3 mRNA and protein expression levels in Huh7 cells following SOX2 knockdown and overexpression. n = 6; ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, HCC: Hepatocellular carcinoma, FOXJ3: Forkhead box J3, qRT-PCR: Quantitative reverse transcription polymerase chain reaction.

    Journal: CytoJournal

    Article Title: SOX2 promotes the progression of hepatocellular carcinoma by targeting FOXJ3 and activating the PI3K/AKT pathway to regulate autophagy and mitophagy

    doi: 10.25259/Cytojournal_164_2025

    Figure Lengend Snippet: SOX2 regulates the expression of FOXJ3 in HCC. (a-c) qRT-PCR and Western blot analysis of FOXJ3 mRNA and protein expression levels in Huh7 cells following SOX2 knockdown and overexpression. n = 6; ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, HCC: Hepatocellular carcinoma, FOXJ3: Forkhead box J3, qRT-PCR: Quantitative reverse transcription polymerase chain reaction.

    Article Snippet: Human normal liver epithelial cells (THLE-2, CL-0833) and HCC cells (Huh7, CL-0120) were purchased from Procell (Wuhan, Hubei, China).

    Techniques: Expressing, Quantitative RT-PCR, Western Blot, Knockdown, Over Expression, Reverse Transcription, Polymerase Chain Reaction

    SOX2 regulates autophagy and mitophagy in HCC cells by regulating FOXJ3. (a-c) Western blot analysis of the effects of SOX2 and FOXJ3 on the expression levels of autophagy-related proteins LC3II, LC3I, and p62. (d) Transmission electron microscopic observation of autophagosome formation in HCC cells under SOX2 and FOXJ3 modulation. Scale bar: 50 nm. (e-g) Western blot analysis of the effects of SOX2 and FOXJ3 on mitophagy-related proteins PINK1, phosphorylated COX4 (p-COX4), and COX4. (h and i) Immunofluorescence assay assessing the colocalization of mitochondria and lysosomes upon SOX2 and FOXJ3 expression. (h) Magnification = ×200, Scale bar: 50 μm. n = 6; ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, HCC: Hepatocellular carcinoma, FOXJ3: Forkhead box J3.

    Journal: CytoJournal

    Article Title: SOX2 promotes the progression of hepatocellular carcinoma by targeting FOXJ3 and activating the PI3K/AKT pathway to regulate autophagy and mitophagy

    doi: 10.25259/Cytojournal_164_2025

    Figure Lengend Snippet: SOX2 regulates autophagy and mitophagy in HCC cells by regulating FOXJ3. (a-c) Western blot analysis of the effects of SOX2 and FOXJ3 on the expression levels of autophagy-related proteins LC3II, LC3I, and p62. (d) Transmission electron microscopic observation of autophagosome formation in HCC cells under SOX2 and FOXJ3 modulation. Scale bar: 50 nm. (e-g) Western blot analysis of the effects of SOX2 and FOXJ3 on mitophagy-related proteins PINK1, phosphorylated COX4 (p-COX4), and COX4. (h and i) Immunofluorescence assay assessing the colocalization of mitochondria and lysosomes upon SOX2 and FOXJ3 expression. (h) Magnification = ×200, Scale bar: 50 μm. n = 6; ✶ ✶ ✶ P <0.001. SOX2: SRY-box transcription factor 2, HCC: Hepatocellular carcinoma, FOXJ3: Forkhead box J3.

    Article Snippet: Human normal liver epithelial cells (THLE-2, CL-0833) and HCC cells (Huh7, CL-0120) were purchased from Procell (Wuhan, Hubei, China).

    Techniques: Western Blot, Expressing, Transmission Assay, Immunofluorescence